Skip to main content
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.530
-0.160 (-9.47%)
Apr 25, 2025, 1:38 PM EDT - Market open

Celularity Revenue

Celularity had revenue of $9.30M in the quarter ending September 30, 2024, with 145.54% growth. This brings the company's revenue in the last twelve months to $48.20M, up 225.94% year-over-year. In the year 2023, Celularity had annual revenue of $22.77M with 26.68% growth.

Revenue (ttm)
$48.20M
Revenue Growth
+225.94%
P/S Ratio
0.74
Revenue / Employee
$401,667
Employees
120
Market Cap
34.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M-6.87M-32.48%
Dec 31, 201921.15M3.59M20.47%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

CELU News

More News